RXQ Compounding

Employees of RXQ Compounding are seen at work at the Ohio University Innovation Center in this file photo of a clean room. The company is building its own manufacturing facility at Albany.

Note: This story appears in the Sunday, June 23 newspaper on Page A3.

An Athens County company that manufactures sterile products for veterinary and human medical use issued a nationwide voluntary recall on Tuesday.

RXQ Compounding has also suspended all sterile production at its Athens facility (located at the Ohio University Innovation Center) until it moves production into its new facility in Albany.

Company founder Ed Zatta told The Messenger on June 5 that it would be about a month before the move is made to the new manufacturing facility.

The Messenger received the company’s recall announcement from the U.S. Food and Drug Administration.

The company declined comment when contacted Friday, but said a statement would be issued Monday.

“To date, RXQ has not received reports of any adverse events related to the sterile product being recalled,” said Tuesday’s announcement.

However, according to the announcement, the recall is being made “out of an abundance of caution” because sterility of the products cannot be assured.

It also stated that the administration of non-sterile products that are intended to be sterile can result in serious injury or death.

The company is notifying its customers by letter and is arranging for return of all recalled products.

“Hospitals and practitioners that have these products being recalled should stop using them,” the announcement states.

Several medical-related websites have reported the recall.

The company advises customers to contact their physician or healthcare provider if they have any problems that might be related to taking or using the products.

Load comments